Cargando…

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes

BACKGROUND: The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance and is associated with major adverse cardiovascular events (MACEs) in patients with type 2 diabetes mellitus (T2DM). However, the long-term effect of the TyG index on the incidence of MACEs remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tai, Shi, Fu, Liyao, Zhang, Ningjie, Yang, Rukai, Zhou, Yuying, Xing, Zhenhua, Wang, Yongjun, Zhou, Shenghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400318/ https://www.ncbi.nlm.nih.gov/pubmed/35999546 http://dx.doi.org/10.1186/s12933-022-01599-1

Ejemplares similares

Impact of Baseline and Trajectory of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
por: Tai, Shi, et al.
Publicado: (2022)

Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
por: Fu, Liyao, et al.
Publicado: (2021)

Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
por: Fu, Liyao, et al.
Publicado: (2022)

Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
por: Yang, Kun, et al.
Publicado: (2021)

The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk
por: Hayıroğlu, Mert İlker, et al.
Publicado: (2022)

Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
por: Guo, Qianyun, et al.
Publicado: (2022)

Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
por: Tao, Shiyi, et al.
Publicado: (2023)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients
por: Colladant, Mathilde, et al.
Publicado: (2023)

Dapagliflozin impedes endothelial cell senescence by activating the SIRT1 signaling pathway in type 2 diabetes
por: Tai, Shi, et al.
Publicado: (2023)

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Triglyceride-glucose index on risk of adverse events after drug-coated balloon angioplasty
por: Lin, Zhaorong, et al.
Publicado: (2023)

Triglyceride–glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension
por: Liu, Yahui, et al.
Publicado: (2023)

Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study
por: Cui, Haozhe, et al.
Publicado: (2022)

Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study
por: Wu, Zhenguo, et al.
Publicado: (2022)

Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke
por: Zhou, Yimo, et al.
Publicado: (2020)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Triglyceride−glucose index in the prediction of major adverse cardiovascular events in patients with type 2 diabetes mellitus after coronary artery bypass surgery: A retrospective cohort study
por: Zhang, He, et al.
Publicado: (2022)

The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis
por: Li, Sangsang, et al.
Publicado: (2019)

Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
por: Quiroga, Borja, et al.
Publicado: (2022)

The predictive value of the triglyceride—glucose index for cardiovascular events in patients with coronary chronic total occlusion
por: Li, Yingkai, et al.
Publicado: (2022)

Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event
por: Qu, Hua, et al.
Publicado: (2023)

The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study
por: Wu, Zhenguo, et al.
Publicado: (2023)

Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study
por: Zheng, Huancong, et al.
Publicado: (2023)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Correction to: Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
Publicado: (2023)

Temporal relationship between triglyceride-glucose index and blood pressure and their joint cumulative effect on cardiovascular disease risk: a longitudinal cohort study
por: Wu, Kuangyi, et al.
Publicado: (2023)

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk
por: Cai, Xiao-ling, et al.
Publicado: (2023)

Association between triglyceride-glucose index and risk of cardiovascular disease among postmenopausal women
por: Liu, Qian, et al.
Publicado: (2023)

Association Between Metabolic Syndrome and an Increased Risk of Hospitalization for Heart Failure in Population of HFpEF
por: Zhou, Ying, et al.
Publicado: (2021)

Independent and joint associations between the triglyceride-glucose index and NT-proBNP with the risk of adverse cardiovascular events in patients with diabetes and acute coronary syndrome: a prospective cohort study
por: Wang, Man, et al.
Publicado: (2023)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

Predictive Effect of Triglyceride-Glucose Index on Adverse Prognostic Events in Patients with Type 2 Diabetes Mellitus and Ischemic Cardiomyopathy
por: Abuduaini, Baiheremujiang, et al.
Publicado: (2023)

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
por: Alizargar, Javad, et al.
Publicado: (2020)

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
por: Tao, Li-Chan, et al.
Publicado: (2022)

Triglyceride glucose index: A new biomarker in predicting cardiovascular risk
por: Araújo, Susilane Pereira, et al.
Publicado: (2022)

Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study
por: Wang, Anxin, et al.
Publicado: (2021)

Impact of Visit-to-Visit Triglyceride-Glucose Index Variability on the Risk of Cardiovascular Disease in the Elderly
por: Chen, Fei, et al.
Publicado: (2022)

Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus
por: Liu, Dong, et al.
Publicado: (2022)

Relationship of cumulative exposure to the triglyceride-glucose index with ischemic stroke: a 9-year prospective study in the Kailuan cohort
por: Wang, Xianxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bgr1p0uikv3fl6p73147b8kgul